Jerusha Mogaka
Datos Biográficos
| ID | 9063348 |
|---|---|
| NOMBRE | Jerusha Mogaka |
| NOMBRES | Jerusha |
| APELLIDO | Mogaka |
| FIRMA | MOGAKA J |
| VERIFICADO | No |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2026 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Evaluating the safety of prenatal HIV PrEP use
Existing data support the safety of daily oral tenofovir disoproxil fumarate (TDF)-based HIV pre-exposure prophylaxis (PrEP) use in pregnancy, yet ongoing monitoring is needed. We analyzed data from three recently completed HIV PrEP safety and implementation studies (PrIMA, PrIMA-X, and mWACh-PrEP) that enrolled women who were offered and/or initiated TDF-based HIV PrEP at routine health clinics in Western Kenya to summarize perinatal outcomes fo…
Sin obras prominentes en esta página.
Evaluating the safety of prenatal HIV PrEP use
Existing data support the safety of daily oral tenofovir disoproxil fumarate (TDF)-based HIV pre-exposure prophylaxis (PrEP) use in pregnancy, yet ongoing monitoring is needed. We analyzed data from three recently completed HIV PrEP safety and implementation studies (PrIMA, PrIMA-X, and mWACh-PrEP) that enrolled women who were offered and/or initiated TDF-based HIV PrEP at routine health clinics in Western Kenya to summarize perinatal outcomes fo…
Cohort (1 obras) · Cohort study (1 obras) · Gestation (1 obras) · Gestational age (1 obras) · HIV-related health complications and treatments (1 obras) · HIV/AIDS drug development and treatment (1 obras) · HIV/AIDS Research and Interventions (1 obras) · Human immunodeficiency virus (HIV) (1 obras) · Poisson regression (1 obras) · Pre-exposure prophylaxis (1 obras)